Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-STEAP2 antibodies, antibody-drug conjugates, and bispecific antigen-binding molecules that bind STEAP2 and CD3, and uses thereof

Anti-STEAP2 antibodies, antibody-drug conjugates, and bispecific antigen-binding molecules that bind STEAP2 and CD3, and uses thereof

US Patent 11633501 · Granted Apr 25, 2023

Estimated economic value: $337,292,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibodies comprising chimeric constant domains2025
Heavy chain constant regions with reduced binding to Fc gamma receptors2025
Anti-MSR1 antibodies and methods of use thereof2025
Methods for treatment using chimeric antigen receptors specific for B-cell matur2025
Bispecific anti-PSMA x anti-CD28 antibodies and uses thereof2025
Bispecific anti-PSMA x anti-CD28 antibodies and uses thereof2025
Chimeric antigen receptors specific for B-cell maturation antigen and encoding p2025
Non-human animals expressing humanized CD3 complex2025
Diels-Alder conjugation methods2025
EGFR x CD28 multispecific antibodies2025
Antigen binding molecule formats2025
Biologically active molecules, conjugates thereof, and therapeutic uses2025